Think Research Corp (TSXV:THNK)
C$ 0.315 0 (0%) Market Cap: 24.82 Mil Enterprise Value: 71.97 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

Think Research Corporation SNN Network Webcast Transcript

Dec 30, 2021 / NTS GMT
Release Date Price: C$1.37 (+3.01%)
Unidentified Analyst

Welcome to the SNN Network Canada Virtual Event. I'd like to introduce our next presenter, Sachin Aggarwal, CEO of Think Research. Sachin, the floor is yours.

Sachin Aggarwal
Think Research Corporation - CEO & Director

All right. Thank you so much, and thanks, folks, for taking the time this morning to see our presentation. My name is Sachin Aggarwal, and I'm the CEO of Think Research. We are a young public company, having listed on the TSX Venture Exchange less than a year ago, late in December of 2020 and had a lot of change, a lot of growth over that period.

So let me just take you through our story, and again, thanks for spending time with us. Think Research is a software company, and what we do is we get the latest in clinical knowledge and clinical evidence out to the point of care so that doctors, nurses, pharmacists that practice in our clinics, in our hospitals and across health systems practice up-to-date medicine, all right?

So what we do is we get new evidence and new best practice into the hands of those care

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot